Identification of <i>ATRNL1</i> and <i>WNT9A</i> as novel key genes and drug candidates in hypertrophic cardiomyopathy: integrative bioinformatics and experimental validation.

导出 LinkOut

翻译打印收藏纠错

第一作者： Huabin,He

第一单位： Department of Cardiovascular Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.;Department of Cardiovascular Medicine, Jiu jiang NO. 1 People's Hospital, Jiujiang, China.

作者： Huabin,He ^[1] ; Yanhui,Liao ^[2] ; Yang,Chen ^[2] ; Hao,Qin ^[2] ; Longlong,Hu ^[2] ; Shucai,Xiao ^[2] ; Huijian,Wang ^[2] ; Renqiang,Yang ^[2]

作者单位： Department of Cardiovascular Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.;Department of Cardiovascular Medicine, Jiu jiang NO. 1 People's Hospital, Jiujiang, China. ^[1] Department of Cardiovascular Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. ^[2]

关键词 ATRNL1 Wnt9a bioinformatics hsa-miR-1469 hypertrophic cardiomyopathy

DOI 10.3389/fmolb.2024.1458434

PMID 39329089

发布时间 2024-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in molecular biosciences

2024年11卷

1458434页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Identification of <i>ATRNL1</i> and <i>WNT9A</i> as novel key genes and drug candidates in hypertrophic cardiomyopathy: integrative bioinformatics and experimental validation.

Frontiers in molecular biosciences

相似文献

Frontiers in molecular biosciences

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Identification of <i>ATRNL1</i> and <i>WNT9A</i> as novel key genes and drug candidates in hypertrophic cardiomyopathy: integrative bioinformatics and experimental validation.

Frontiers in molecular biosciences

相似文献

Frontiers in molecular biosciences

相关期刊

检索历史清除